Cargando…

Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women

BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FP...

Descripción completa

Detalles Bibliográficos
Autores principales: Ren, Yanfeng, Jin, Longmei, Yang, Fen, Liang, Hong, Zhang, Zhaofeng, Du, Jing, Song, Xiuxia, Miao, Maohua, Yuan, Wei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433207/
https://www.ncbi.nlm.nih.gov/pubmed/32807188
http://dx.doi.org/10.1186/s12940-020-00640-8
_version_ 1783571960244994048
author Ren, Yanfeng
Jin, Longmei
Yang, Fen
Liang, Hong
Zhang, Zhaofeng
Du, Jing
Song, Xiuxia
Miao, Maohua
Yuan, Wei
author_facet Ren, Yanfeng
Jin, Longmei
Yang, Fen
Liang, Hong
Zhang, Zhaofeng
Du, Jing
Song, Xiuxia
Miao, Maohua
Yuan, Wei
author_sort Ren, Yanfeng
collection PubMed
description BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FPG) and one-hour plasma glucose (1 h-PG) after a 50-g oral glucose tolerance test in pregnant women. METHODS: The study was based on the Shanghai-Minhang Birth Cohort, in which 1292 pregnant women were recruited. Among them, 981 women provided blood samples (at 12–16 gestational weeks) for PFAS measurement. FPG data collected from 856 women at 12–20 GW and 1 h-PG data collected from 705 women at 20–28 GW were obtained through medical records from the routine prenatal care system. High FPG or 1 h-PG was defined as ≥90th percentile of FPG or 1 h-PG. The analysis of eight PFASs was conducted in this study: perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), and perfluorotridecanoic acid (PFTrDA). The odds ratios (ORs) and associated 95% confidence intervals (CIs) were estimated to determine the associations of each PFAS compound with high FPG and 1 h-PG from a logistic regression model. RESULTS: After adjustment for potential confounders, most PFASs were positively associated with high 1 h-PG concentrations. The OR for high 1 h-PG concentrations was 1.87 (95% CI: 1.15–3.05) with a one log unit increase of PFOS; similar associations were observed for PFNA (OR: 2.15, 95% CI: 1.24–3.74), PFDA (OR: 1.61, 95% CI: 1.10–2.44), PFUdA (OR: 1.71, 95% CI: 1.12–2.62), and PFDoA (OR: 1.34, 95% CI: 1.00–1.81). When the PFAS concentrations were categorized into three groups by tertiles, the highest tertiles of PFOS, PFOA, PFNA, PFDA, PFDoA, and PFTrDA had a statistically significant increase in the risk of high 1 h-PG concentrations compared with the lowest tertiles. No statistically significant association was observed between PFAS exposure and high FPG. CONCLUSION: PFAS exposure was associated with an increased risk of high 1 h-PG among pregnant women, but no such association was observed for FPG.
format Online
Article
Text
id pubmed-7433207
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-74332072020-08-19 Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women Ren, Yanfeng Jin, Longmei Yang, Fen Liang, Hong Zhang, Zhaofeng Du, Jing Song, Xiuxia Miao, Maohua Yuan, Wei Environ Health Research BACKGROUND: Evidence on the association between exposure to perfluoroalkyl and polyfluoroalkyl substances (PFASs) and blood glucose concentrations in pregnant women is inconsistent. This study aimed to examine the association between PFAS exposure and the concentrations of fasting plasma glucose (FPG) and one-hour plasma glucose (1 h-PG) after a 50-g oral glucose tolerance test in pregnant women. METHODS: The study was based on the Shanghai-Minhang Birth Cohort, in which 1292 pregnant women were recruited. Among them, 981 women provided blood samples (at 12–16 gestational weeks) for PFAS measurement. FPG data collected from 856 women at 12–20 GW and 1 h-PG data collected from 705 women at 20–28 GW were obtained through medical records from the routine prenatal care system. High FPG or 1 h-PG was defined as ≥90th percentile of FPG or 1 h-PG. The analysis of eight PFASs was conducted in this study: perfluorohexane sulfonate (PFHxS), perfluorooctane sulfonate (PFOS), perfluorooctanoic acid (PFOA), perfluorononanoic acid (PFNA), perfluorodecanoic acid (PFDA), perfluoroundecanoic acid (PFUdA), perfluorododecanoic acid (PFDoA), and perfluorotridecanoic acid (PFTrDA). The odds ratios (ORs) and associated 95% confidence intervals (CIs) were estimated to determine the associations of each PFAS compound with high FPG and 1 h-PG from a logistic regression model. RESULTS: After adjustment for potential confounders, most PFASs were positively associated with high 1 h-PG concentrations. The OR for high 1 h-PG concentrations was 1.87 (95% CI: 1.15–3.05) with a one log unit increase of PFOS; similar associations were observed for PFNA (OR: 2.15, 95% CI: 1.24–3.74), PFDA (OR: 1.61, 95% CI: 1.10–2.44), PFUdA (OR: 1.71, 95% CI: 1.12–2.62), and PFDoA (OR: 1.34, 95% CI: 1.00–1.81). When the PFAS concentrations were categorized into three groups by tertiles, the highest tertiles of PFOS, PFOA, PFNA, PFDA, PFDoA, and PFTrDA had a statistically significant increase in the risk of high 1 h-PG concentrations compared with the lowest tertiles. No statistically significant association was observed between PFAS exposure and high FPG. CONCLUSION: PFAS exposure was associated with an increased risk of high 1 h-PG among pregnant women, but no such association was observed for FPG. BioMed Central 2020-08-17 /pmc/articles/PMC7433207/ /pubmed/32807188 http://dx.doi.org/10.1186/s12940-020-00640-8 Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Ren, Yanfeng
Jin, Longmei
Yang, Fen
Liang, Hong
Zhang, Zhaofeng
Du, Jing
Song, Xiuxia
Miao, Maohua
Yuan, Wei
Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title_full Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title_fullStr Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title_full_unstemmed Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title_short Concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
title_sort concentrations of perfluoroalkyl and polyfluoroalkyl substances and blood glucose in pregnant women
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7433207/
https://www.ncbi.nlm.nih.gov/pubmed/32807188
http://dx.doi.org/10.1186/s12940-020-00640-8
work_keys_str_mv AT renyanfeng concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT jinlongmei concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT yangfen concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT lianghong concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT zhangzhaofeng concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT dujing concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT songxiuxia concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT miaomaohua concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen
AT yuanwei concentrationsofperfluoroalkylandpolyfluoroalkylsubstancesandbloodglucoseinpregnantwomen